Harvard Management CO Inc Royalty Pharma PLC Transaction History

Harvard Management CO Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	SELL	$37.46 - $42.44 $130 Million - $147 Million	-3,464,990 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$35.17 - $42.48 $129 Million - $156 Million	-3,677,866 Reduced 51.49%	3,464,990 $138 Million
Q2 2021 Aug 13, 2021	SELL	$39.85 - $46.63 $142 Million - $167 Million	-3,571,428 Reduced 33.33%	7,142,856 $293 Million
Q1 2021 May 07, 2021	SELL	$42.34 - $52.82 $168 Million - $210 Million	-3,976,496 Reduced 27.07%	10,714,284 $467 Million
Q2 2020 Sep 18, 2020	BUY	$44.5 - $52.11 $654 Million - $766 Million	14,690,780 New	14,690,780 $713 Million

412

283M

578K

47.5K

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $11.2B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

Get notified when there are updates to the investment portfolio of Harvard Management CO Inc, based on Form 13F filings with the SEC.

Stay updated on Harvard Management CO Inc with notifications on news.